 MENLO PARK, Calif., Aug. 29, 2022 GLOBE NEWSWIRE -- AN2 Therapeutics, Inc. Nasdaq: ANTX, a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that Eric Easom, President and CEO will present at the H.C. Wainwright 24th Annual Global Investment Conference 